Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Transkriptomska razčlenitev napredovalih primarnih tumorjev endometrija glede na status popravljanja neujemanja : Dopolnilne slike in dopolnilne tabele
Authors:ID Gjorgoska, Marija (Author)
ID Lanišnik-Rižner, Tea (Author)
Files:.pdf PDF - Presentation file, download (303,54 KB)
MD5: 1F88187AC4B0311CB788432A4A67220A
 
.xlsx XLSX - Presentation file, download (1,59 MB)
MD5: C2F8DEDE099B9B2D18C729800DF39DBB
 
Language:Slovenian
Organization:Logo OI - Institute of Oncology
Abstract:Dopolnilne slike in dopolnilne tabele k članku Transkriptomska razčlenitev napredovalih primarnih tumorjev endometrija glede na status popravljanja neujemanja (avtorici Gjorgoska Marija, Lanišnik Rižner Tea), objavljenim v reviji Onkologija št.1, jun. 2026.
Keywords:napredovali rak endometrija, popravljanje neujemanja (MMR), imunoterapija, transkriptomska analiza, terapevtske tarče
Publication status:Published
Publication version:Version of Record
Submitted for review:13.11.2025
Article acceptance date:12.02.2026
Publication date:14.04.2026
Place of publishing:Ljubljana
Publisher:Onkološki inštitut Ljubljana
Year of publishing:2026
PID:20.500.12556/DiRROS-28918 New window
Copyright:by Authors
Publication date in DiRROS:14.04.2026
Views:132
Downloads:80
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:English
Title:Transcriptomic stratification of advanced primary endometrial tumors by mismatch repair status : Supplementary figures and supplementary tables
Keywords:advanced endometrial cancer, mismatch repair (MMR), immunotherapy, transcriptomic analysis, therapeutic targets


Back